
Psychiatry
Latest News
CME Content




New research finds posttraumatic growth is an important positive factor in life satisfaction for patients with HIV, even after controlling for the negative consequences of stigma and disclosure regret.

In a clinical trial, the reSET-O app increased retention in an outpatient opioid use disorder treatment program.

Investigator Anita Clayton, MD, shares insights into the new vortioxetine data and its implications for patients with depression and treatment-emergent sexual dysfunction.

About half of all MS patients experience an episode of depression during their lifetimes, but most interventions are drug-related or psychiatric.

Most of the patients in the study were taking concomitant antidepressants and/or antipsychotics, and mood disorders remained stable during treatment with valbenazine.

Healthcare provider employment opportunies have risen 7.1%—an increase from 2017's reported rate of 5%. Where are the jobs in most demand?

With a recent FDA approval as the first ever therapy for TD, as well as the first ongoing phase 4 clinical trial, valbenazine use is under close watch by clinicians and specialists.

Patients with tardive syndromes treated with transcranial magnetic stimulation had greater improvement in AIMS scores compared to the sham group.

Ezogabine was not marked as an antidepressant but seemed to be an effective treatment in a small study.

Research with more diverse patient populations is needed to confirm this new discovery.

A meta-analysis of more than 7 million patients confirms that just 1 instance of a concussion or mild TBI is associated with a two-fold greater risk of suicide.

Tardive dyskinesia due to lithium treatment is still rare, but the antipsyhotic therapy substitute was linked to at least 1 particular patient case.

The use of mood-altering medications does not increase odds for hepatic encephalopathy or hepatic encephalopathy-related hospital admissions after TIPS placement, according to the results of a new study.

Patients may have been told they would ‘grow out of’ PKU, and consequently go off-diet, with consequences such as cognitive deficit.

A study of deep brain stimulation in patients with tardive dyskinesia and dystonia reports promising results.

Long-term lung inflammation associated with allergen exposure is linked to the development of anxiety later in adulthood, according to a new study.

A retrospective review finds HIV post-exposure prophylaxis is often prescribed outside of guidelines’ recommendations in response to patients' emotional stress.

A supplemental new drug application (sNDA) for vortioxetine (TRINTELLIX), a prescription medication for the treatment of adults with major depressive disorder (MDD), has been accepted by the FDA.

Increased access to proper mental health care is a key weapon in the battle against the deadly opioid epidemic, according to a recent study.

People with depression exhibit an unexpected increase in volume on the left side of the hypothalamus, the brain region responsible for physical wellbeing.

Patients receiving valbenazine for tardive dyskinesia reported high levels of satisfaction, even after up to 2 years of treatment.

Long-term treatment with valbenazine improved tardive dyskinesia symptoms over 48 weeks.









































































